Home » Stocks » BSX

Boston Scientific Corporation (BSX)

Stock Price: $45.60 USD 0.28 (0.62%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $45.79 +0.19 (0.42%) Jul 30, 7:44 PM
Market Cap 64.79B
Revenue (ttm) 10.12B
Net Income (ttm) 201.00M
Shares Out 1.42B
EPS (ttm) 0.37
PE Ratio 123.58
Forward PE 28.17
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $45.60
Previous Close $45.32
Change ($) 0.28
Change (%) 0.62%
Day's Open 45.19
Day's Range 45.01 - 45.93
Day's Volume 9,108,233
52-Week Range 32.99 - 46.03

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Final Trades: Salesforce, Amazon, Boston Scientific & more

YouTube video

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: CRM
2 days ago - CNBC Television

Boston Scientific (NYSE:BSX) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY21 EPS guidance with a midpoint above analyst e...

5 days ago - Benzinga

Organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in Q2.

5 days ago - Zacks Investment Research

Boston Scientific (BSX) delivered earnings and revenue surprises of 8.11% and 4.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 days ago - Zacks Investment Research

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.1 billion in Q2 of 2021, beating the estimate of $2.9 billion. Sales increased 53.6% Y/Y on a reported basis and 52.4% on an organic b...

5 days ago - Benzinga

Shares of Boston Scientific (NYSE:BSX) fell 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year over year to $0.40, which beat t...

5 days ago - Benzinga

MARLBOROUGH, Mass., July 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.077 billion during the second quarter of 2021, growing 53.6 percent on a reported ba...

5 days ago - PRNewsWire

Boston Scientific (BSX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

6 days ago - Zacks Investment Research

Boston Scientific is scheduled to report its Q2 2021 results on Tuesday, July 27. We expect Boston Scientific to report revenues and earnings in-line with the consensus estimates, driven by a rebound in...

1 week ago - Forbes

Strong procedure recovery and market share gains across many of the businesses and regions are expected to have boosted Boston Scientific's (BSX) Q2 sales.

1 week ago - Zacks Investment Research

The stock price of ​Boston Scientific reached its 52-week high of $44 in April this year before a recent sell-off in broader markets, which led to a 7% drop in BSX stock to levels of around $41 currentl...

1 week ago - Forbes

MARLBOROUGH, Mass., July 21, 2021 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive 24-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the n...

1 week ago - PRNewsWire

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

Barron's, a famous weekly financial newspaper, organizes an annual roundtable with prominent U.S. investors where they discuss the market and give their opinions on their best ideas for stocks.

Other stocks mentioned: AMT, BDX, SPGI
1 week ago - GuruFocus

NVST vs. BSX: Which Stock Is the Better Value Option?

Other stocks mentioned: NVST
1 month ago - Zacks Investment Research

MARLBOROUGH, Mass., June 29, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter e...

1 month ago - PRNewsWire

Boston Scientific (BSX) currently holds an equity stake of roughly 27%.

1 month ago - Zacks Investment Research

MARLBOROUGH, Mass., June 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of David S.

1 month ago - PRNewsWire

The following are the best-performing stocks over the past six months that have a long-term presence in more than five gurus' portfolios.

Other stocks mentioned: BIG, GILD, QRTEA, SU
1 month ago - GuruFocus

MARLBOROUGH, Mass., June 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire the remaining shares of Farapulse, Inc. The acquisition wil...

1 month ago - PRNewsWire

These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.

Other stocks mentioned: ABT, BDX, EW, MDT, MMSI
1 month ago - Zacks Investment Research

We believe that the stock price of ​Boston Scientific (NYSE: BSX) is undervalued at current levels of $43. BSX stock is up 65% from the levels of around $26 it was at on March 23, 2020, underperforming ...

1 month ago - Forbes

Which one of these medical device makers is better poised for a breakout year?

Other stocks mentioned: MDT
1 month ago - The Motley Fool

The European market release of Boston Scientific's (BSX) EXALT Model B Single-Use Bronchoscope will mitigate infection risks associated with reusable imaging scopes.

1 month ago - Zacks Investment Research

With the trading day more than halfway over, the markets had dipped after a relatively strong start to the day.

Other stocks mentioned: TAP, TAP.A
2 months ago - 24/7 Wall Street

Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXAL...

2 months ago - PRNewsWire

Big call buying in Boston Scientific

YouTube video

"Halftime Report" trader Pete Najarian spots unusual activity in the options market

2 months ago - CNBC Television

MARLBOROUGH, Mass., May 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 37th Annual Strategic Decisions Conference on Friday, June 4, 2021.

2 months ago - PRNewsWire

MARLBOROUGH, Mass., May 18, 2021 /PRNewswire/ -- Data presented at hotline and late-breaking trial sessions today at the EuroPCR 2021 congress demonstrated positive procedural performance, including low...

2 months ago - PRNewsWire

The stock price of Boston Scientific has corrected 3.5% over the last five trading sessions, and the dip appears to be a good buying opportunity in our view. Not only did the company post an upbeat perf...

2 months ago - Forbes

Investors are optimistic about Boston Scientific (BSX) owing to its solid first-quarter performance and impressive value-added acquisitions.

2 months ago - Zacks Investment Research

Like most medical device manufacturers, Boston Scientific Corp. ( BSX , Financial) also witnessed a slowdown in 2020 on account of the lower demand for medical devices and the deferral of elective surge...

2 months ago - GuruFocus

Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.

Other stocks mentioned: CNTG, HOLX, INGN, LH, OMI, XRAY
2 months ago - Zacks Investment Research

MARLBOROUGH, Mass., (May 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

2 months ago - PRNewsWire

Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).

Other stocks mentioned: ASXC, ISRG, JNJ, SYK
2 months ago - Zacks Investment Research

Bulls bet on Boston Scientific and Las Vegas Sands

YouTube video

"Halftime Report" trader Pete Najarian spots unusual activity in the options market

Other stocks mentioned: LVS
3 months ago - CNBC Television

Boston Scientific Corporation (NYSE: BSX) Q1 sales grew by 5.9% (organically) to $2.75 billion, beating the previous guidance range between negative 3% and 3% in the quarter, better than the consensus e...

3 months ago - Benzinga

Boston Scientific (BSX) registers strong sequential improvement in overall financial performance in Q1.

3 months ago - Zacks Investment Research

Boston Scientific (BSX) delivered earnings and revenue surprises of 23.33% and 5.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021.

3 months ago - PRNewsWire

Boston Scientific (BSX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

3 months ago - Zacks Investment Research

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Other stocks mentioned: ABT, ALGN, DGX, HOLX, IART
3 months ago - Zacks Investment Research

Within Boston Scientific's (BSX) coronary therapies, drug-eluting stents sale continue to be a challenge from a pricing standpoint in Q1.

3 months ago - Zacks Investment Research

Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

EVP&Pres, Periph Intervent of Boston Scientific Corp (30-Year Financial, Insider Trades) Jeffrey B. Mirviss (insider trades) sold 28,123 shares of BSX on 04/15/2021 at an average price of $40.95 a share.

3 months ago - GuruFocus

Final Trades: Northrop Grumman, Boston Scientific, Nvidia & more

YouTube video

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: NOC, NVDA, AAPL
3 months ago - CNBC Television

With the trading day about halfway over, the broad markets were pushing much higher with solid gains across the board.

Other stocks mentioned: AMD, INTC, NVDA, AEO, CAKE, CBRL, EW
3 months ago - 24/7 Wall Street

Boston Scientific's (BSX) TheraSphere is expected to be used as a safe and effective treatment option for numerous HCC patients worldwide on the back of positive trial results.

4 months ago - Zacks Investment Research

MARLBOROUGH, Mass., March 26, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter e...

4 months ago - PRNewsWire

Boston Scientific (BSX) currently expects its 2021 organic revenues to include a headwind of $62 million from 2020 LOTUS Edge sales.

4 months ago - Zacks Investment Research

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and r... [Read more...]

Industry
Medical Devices
IPO Date
May 18, 1992
CEO
Michael Mahoney
Employees
38,000
Stock Exchange
NYSE
Ticker Symbol
BSX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 27 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is 48.97, which is an increase of 7.39% from the latest price.

Price Target
$48.97
(7.39% upside)
Analyst Consensus: Strong Buy